Facilitating cancer research with antibodies
Cancer is one of the leading causes of death worldwide, accounting for almost 10 million deaths in 2020[1]. To aid research in the field of cancer, IQ Products offers antibodies against several general biomarkers and biomarkers associated with a specific type of cancer. The portfolio has a focus towards cancers related to women’s health, including markers for the research in ovarian cancer and cervical cancer.
Cancers that predominantly affect women
Breast cancer, cervical cancer, ovarian cancer, and uterine/endometrial cancer have a significant impact on the health of women[2]. Detection and diagnosis of the cancer in an early stage improves the prognosis of the patient[3]. In an early stage, there are more treatment options available, often also less invasive, and with better survival rates[4].
One of the current challenges is to identify accurate biomarkers for the detection and diagnosis of cancers[5]. Research to gain insight into biomarkers that play a role in the etiology of cancer will lead to better diagnostic methods for the detection of cancer. More importantly, biomarkers that can correctly predict outcomes would play a major role in clinical decision making. For example, improved screening could aid the prediction of the recurrence of a cancer.
Curious to see whether our antibodies can support your research?
Search for specific antibodies per cancer type:
References
- Sung, H., et al., Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin, 2021. 71(3): p. 209-249.
- Torre, L.A., et al., Global Cancer in Women: Burden and Trends. Cancer Epidemiol Biomarkers Prev, 2017. 26(4): p. 444-457.
- Tobore, T.O., On the need for the development of a cancer early detection, diagnostic, prognosis, and treatment response system. Future Sci OA, 2019. 6(2): p. Fso439.
- Henry, N.L. and D.F. Hayes, Cancer biomarkers. Mol Oncol, 2012. 6(2): p. 140-6.
- Diamandis, E.P., Present and future of cancer biomarkers. Clin Chem Lab Med, 2014. 52(6): p. 791-4.